Login
← Go Back
Viyash Scientific
VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in
Stock Price vs Company Growth
1d
2.2%
1w
6.3%
1m
11.5%
3m
16.5%
6m
6.6%
1y
8.9%
5y
1.1%
10y
5.6%
all
2.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 221 2.2%
219
281
Company Overview
Sales
3,149 Cr
Growth: 25.2%
Profit after Tax
171 Cr
Growth: 24.8%
Mid Cap
9,765 Cr
P/E: 54.0x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 3,149
Growth 25.2%
EBITDA 18.9%
P/S 3.1x
Dividend 0.0%
P/E 54.0x
Book Value ₹ 67.4
PEG Ratio 2.2x
ROE 9.2%
P/B 3.4x
Shareholding Pattern
Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Others
Increase    Decrease    No change
Company Profile Detailed
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Belongs to (13 Indices) view more
Investors (91)
dilip.sh...
harish.n...
kalpana....
Followers (7)
jose4
joy2
ratnesh2